Paul R. Fonteyne - Jan 6, 2022 Form 3 Insider Report for Amylyx Pharmaceuticals, Inc. (AMLX)

Role
Director
Signature
/s/ Joshua B. Cohen, as Attorney-in-Fact for Paul Fonteyne
Stock symbol
AMLX
Transactions as of
Jan 6, 2022
Transactions value $
$0
Form type
3
Date filed
1/6/2022, 04:06 PM
Previous filing
Jan 4, 2022
Next filing
Jan 24, 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 20,296 shares subject to such stock option shall vest on March 8, 2022 and the remainder of the shares vest in monthly installments of 1,689 shares thereafter.